These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 23210870

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S, Donas KP, Torsello G, Osada N, Herten M.
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [Abstract] [Full Text] [Related]

  • 8. Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population.
    Tekieli L, Pieniazek P, Musialek P, Kablak-Ziembicka A, Przewlocki T, Trystula M, Moczulski Z, Dzierwa K, Paluszek P, Podolec P.
    J Endovasc Ther; 2012 Jun; 19(3):316-24. PubMed ID: 22788881
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Okada K, Kimura T, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M.
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M, Schmidt A, Scheinert S, Banning-Eichenseer U, Ulrich M, Bausback Y, Steiner S, Scheinert D.
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [Abstract] [Full Text] [Related]

  • 12. Carotid artery velocity characteristics after carotid artery angioplasty and stenting.
    Chahwan S, Miller MT, Pigott JP, Whalen RC, Jones L, Comerota AJ.
    J Vasc Surg; 2007 Mar; 45(3):523-6. PubMed ID: 17257803
    [Abstract] [Full Text] [Related]

  • 13. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [Abstract] [Full Text] [Related]

  • 14. Primary carotid artery stenting versus carotid artery stenting for postcarotid endarterectomy stenosis.
    AbuRahma AF, Abu-Halimah S, Bensenhaver J, Nanjundappa A, Stone PA, Dean LS, Keiffer T, Emmett M, Tarakji M, AbuRahma Z.
    J Vasc Surg; 2009 Nov; 50(5):1031-9. PubMed ID: 19703753
    [Abstract] [Full Text] [Related]

  • 15. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon.
    Setacci C, de Donato G, Setacci F, Pieraccini M, Cappelli A, Trovato RA, Benevento D.
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):601-7. PubMed ID: 15878537
    [Abstract] [Full Text] [Related]

  • 16. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W.
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [Abstract] [Full Text] [Related]

  • 17. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Esposito G, Trimarco B, Rubino P.
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [Abstract] [Full Text] [Related]

  • 18. Ultrasound velocity criteria for carotid in-stent restenosis.
    Chi YW, White CJ, Woods TC, Goldman CK.
    Catheter Cardiovasc Interv; 2007 Feb 15; 69(3):349-54. PubMed ID: 17171655
    [Abstract] [Full Text] [Related]

  • 19. Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis.
    Pohlmann C, Höltje J, Zeile M, Bonk F, Urban PP, Brüning R.
    Neuroradiology; 2018 Jan 15; 60(1):81-87. PubMed ID: 29058047
    [Abstract] [Full Text] [Related]

  • 20. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C, Richardt G, Wiemer M, Schneider H, Naber C, Hoffmann E, Dietz U.
    EuroIntervention; 2011 May 15; 7 Suppl K():K119-24. PubMed ID: 22027721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.